drugset / Trial / NCT00002507

Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer

NCT00002507

Phase 3 Completed Yale University
Treatment

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether combining mitomycin or porfiromycin with radiation therapy is more effective in treating patients with head and neck cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy plus either mitomycin or porfiromycin in treating patients with head and neck cancer.

Timeline

Start
1992-11
Primary completion
2002-10
Completion
2002-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitomycin C Other / unclassified
Subject Porfiromycin Small molecule